<DOC>
	<DOCNO>NCT00710307</DOCNO>
	<brief_summary>The purpose protocol describe distribution IGF-1 deficiency study population Idiopathic Short Children without Growth Hormone Deficiency identify cause short stature treat recombinant Growth Hormone IGF-1</brief_summary>
	<brief_title>Epidemiology Study Insulin-like Growth Factor-1 Children With Idiopathic Short Stature ( EPIGROW Study )</brief_title>
	<detailed_description />
	<mesh_term>Dwarfism</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>Short child , height ≤ 2.5 SDS Age ≥ 2 year With least one normal elevate peak GH response stimulatory test ( peak GH ≥ 7 ng/mL ) time study and/or give timepoint last 12 month Prepubertal Signed Informed Consent , include agreement blood sample take hormonal measurement genetic analysis , parent Legally Acceptable Representatives applicable child applicable The following identified cause short stature : GHdeficient short stature Other endocrine cause ( hypothyroidism , Cushing 's syndrome , parathyroid vitamin D disorder , hypogonadism ) Identified syndromes genetic abnormality ( include Turner , Noonan RussellSilver syndrome ) Chronic diseases include malnutrition , coeliac disease , chronic inflammation , muscular dystrophy , thalassaemia , blood disorder , severe liver kidney disease severe cyanotic heart disease Chronic diseases require treatment chronically administer corticosteroid Skeletal dysplasia Psychosocial short stature Patients receive irradiation , include total body irradiation Patients currently GH IGF1 therapy receive GH IGF1 therapy last 12 month Patients likely require GH , IGF1 chronic corticosteroid treatment study Any mental condition prevents parent Legally Acceptable Representatives child applicable understanding nature , scope possible consequence study , evidence uncooperative attitude</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>